- Home
- TRVI vs UCTT Comparison
TRVI vs UCTT Comparison
Compare TRVI & UCTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- UCTT
- Stock Information
- Founded
- TRVI 2011
- UCTT 1991
- Country
- TRVI United States
- UCTT United States
- Employees
- TRVI N/A
- UCTT N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- UCTT Semiconductors
- Sector
- TRVI Health Care
- UCTT Technology
- Exchange
- TRVI Nasdaq
- UCTT Nasdaq
- Market Cap
- TRVI 1.1B
- UCTT 1.1B
- IPO Year
- TRVI 2019
- UCTT 2004
- Fundamental
- Price
- TRVI $9.64
- UCTT $27.63
- Analyst Decision
- TRVI Strong Buy
- UCTT Strong Buy
- Analyst Count
- TRVI 9
- UCTT 3
- Target Price
- TRVI $20.72
- UCTT $39.00
- AVG Volume (30 Days)
- TRVI 2.6M
- UCTT 405.7K
- Earning Date
- TRVI 11-05-2025
- UCTT 10-28-2025
- Dividend Yield
- TRVI N/A
- UCTT N/A
- EPS Growth
- TRVI N/A
- UCTT N/A
- EPS
- TRVI N/A
- UCTT N/A
- Revenue
- TRVI N/A
- UCTT $2,141,100,000.00
- Revenue This Year
- TRVI N/A
- UCTT N/A
- Revenue Next Year
- TRVI N/A
- UCTT $4.45
- P/E Ratio
- TRVI N/A
- UCTT N/A
- Revenue Growth
- TRVI N/A
- UCTT 14.28
- 52 Week Low
- TRVI $2.36
- UCTT $16.66
- 52 Week High
- TRVI $10.16
- UCTT $41.84
- Technical
- Relative Strength Index (RSI)
- TRVI 64.43
- UCTT 54.49
- Support Level
- TRVI $8.24
- UCTT $28.90
- Resistance Level
- TRVI $8.65
- UCTT $30.20
- Average True Range (ATR)
- TRVI 0.51
- UCTT 1.27
- MACD
- TRVI 0.10
- UCTT -0.00
- Stochastic Oscillator
- TRVI 76.06
- UCTT 29.32
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About UCTT Ultra Clean Holdings Inc.
Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.